[Changes in fetal lung maturity after maternal treatment with glucocorticoids].
D000033:Abortion, Threatened / Q000188:drug therapy; D000328:Adult; D000653:Amniotic Fluid / Q000032:analysis; D001623:Betamethasone / Q000627:therapeutic use; D005260:Female; D005325:Fetal Organ Maturity / Q000187:drug effects*; D005938:Glucocorticoids / Q000494:pharmacology* / Q000627:therapeutic use; D006801:Humans; D006819:Hyaline Membrane Disease / Q000517:prevention & control*; D007231:Infant, Newborn; D008168:Lung / Q000187:drug effects / Q000196:embryology*; D007752:Obstetric Labor, Premature / Q000188:drug therapy; D010713:Phosphatidylcholines / Q000032:analysis; D010923:Placenta Previa / Q000188:drug therapy; D011225:Pre-Eclampsia / Q000188:drug therapy; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy*; D013109:Sphingomyelins / Q000032:analysis
D005938:Glucocorticoids; D010713:Phosphatidylcholines; D013109:Sphingomyelins; D001623:Betamethasone
Variazioni della maturità polmonare fetale dopo trattamento materno con glicocorticoidi.